Showing results (81-90 of 9,586) with videos related to
Sort By:
Pageof 959
Clinical Rheumatology|April 5, 2016
Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up studyM A Quintana-Duque, F Rondon-Herrera, R D Mantilla, et al.Clinical Rheumatology|April 7, 2016
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational studyPaolo Sfriso, Francesco Caso, Giuseppe Sebastiano Filardo, et al.Clinical Rheumatology|April 8, 2016
Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire)Nibah Fatimah, Babur Salim, Amjad Nasim, et al.Clinical Rheumatology|March 20, 2016
The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern TurkeyÖmer Nuri Pamuk, Salim Dönmez, Gökçe Büşra Calayır, et al.Clinical Rheumatology|February 18, 2016
The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritisPnina Fishman, Shira CohenClinical Rheumatology|November 8, 2017
Changes and clinical significance of CD8+CD122+ T cells in the peripheral blood of patients with ankylosing spondylitisRenfang Han, Xiao Yang, Mengya Chen, et al.Clinical Rheumatology|August 4, 2016
Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort studyNadeem Ahmed, James A Prior, Ying Chen, et al.Clinical Rheumatology|July 21, 2016
Premedication prevents infusion reactions and improves retention rate during infliximab treatmentFrancesca Bartoli, Cosimo Bruni, Laura Cometi, et al.Clinical Rheumatology|July 27, 2016
Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA)Joanna Lipinska, Stanislawa Lipinska, Marek Kasielski, et al.Clinical Rheumatology|July 30, 2016
A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndromeClaudia Kedor, Jan Zernicke, Anja Hagemann, et al.Pageof 959